Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth Loder, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Loder EW, Burch RC. Who Should Try New Antibody Treatments for Migraine? JAMA Neurol. 2018 Sep 01; 75(9):1039-1040. PMID: 29799961.
    View in: PubMed
  2. Loder E, Rizzoli P. Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018. Headache. 2018 Aug 23. PMID: 30137671.
    View in: PubMed
  3. Merino JG, Loder E, Abbasi K. What readers thought about a research paper's approach to compare treatment effects on mortality. BMJ. 2018 Aug 17; 362:k3213. PMID: 30120093.
    View in: PubMed
  4. Loder E, Weizenbaum E, Giddon D. Migraine Pain Location and Measures of Healthcare Use and Distress: An Observational Study. Pain Res Manag. 2018; 2018:6157982. PMID: 29973968.
    View in: PubMed
  5. Loder EW, Robbins MS. Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea. JAMA. 2018 05 15; 319(19):1985-1987. PMID: 29800193.
    View in: PubMed
  6. Orlova Y, Rizzoli P, Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018 May 01; 75(5):566-572. PMID: 29482205.
    View in: PubMed
  7. Loder E. Children's crusade. BMJ. 2018 03 21; 360:k1305. PMID: 29563090.
    View in: PubMed
  8. Burch R, Rizzoli P, Loder E. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies. Headache. 2018 Apr; 58(4):496-505. PMID: 29527677.
    View in: PubMed
  9. Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E. Guidelines for the Content of Statistical Analysis Plans in Clinical Trials. JAMA. 2017 12 19; 318(23):2337-2343. PMID: 29260229.
    View in: PubMed
  10. Sheikh HU, Pavlovic J, Loder E, Burch R. Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review. Headache. 2018 Jan; 58(1):5-21. PMID: 29139115.
    View in: PubMed
  11. Scher AI, Rizzoli PB, Loder EW. Medication overuse headache: An entrenched idea in need of scrutiny. Neurology. 2017 Sep 19; 89(12):1296-1304. PMID: 28821684.
    View in: PubMed
  12. Joshi S, Rizzoli P, Loder E. The comorbidity burden of patients with cluster headache: a population-based study. J Headache Pain. 2017 Dec; 18(1):76. PMID: 28741257.
    View in: PubMed
  13. Minen MT, Lindberg K, Langford A, Loder E. Variation in Prescription Drug Coverage for Triptans: Analysis of Insurance Formularies. Headache. 2017 Sep; 57(8):1243-1251. PMID: 28691382.
    View in: PubMed
  14. Loder E. The great NHS debate. BMJ. 2017 04 06; 357:j1729. PMID: 28385877.
    View in: PubMed
  15. Loder E. Promises, promises. BMJ. 2017 03 23; 356:j1446. PMID: 28336513.
    View in: PubMed
  16. Merino JG, Jha A, Loder E, Abbasi K. Standing up for science in the era of Trump. BMJ. 2017 02 21; 356:j775. PMID: 28246103.
    View in: PubMed
  17. Loder E. Familiarity breeds better outcomes. BMJ. 2017 Feb 02; 356:j558. PMID: 28153976.
    View in: PubMed
  18. Loder E. Old lessons relearnt. BMJ. 2016 Nov 17; 355:i6153. PMID: 27856442.
    View in: PubMed
  19. Doyle Strauss L, Weizenbaum E, Loder EW, Rizzoli PB. Amitriptyline Dose and Treatment Outcomes in Specialty Headache Practice: A Retrospective Cohort Study. Headache. 2016 Nov; 56(10):1626-1634. PMID: 27775149.
    View in: PubMed
  20. Rizzoli P, Loder E, Joshi S. Validity of cluster headache diagnoses in an electronic health record data repository. Headache. 2016 Jul; 56(7):1132-6. PMID: 27273524.
    View in: PubMed
  21. Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2016 May; 56(5):821-834. PMID: 27143127.
    View in: PubMed
  22. Minen M, Shome A, Halpern A, Tishler L, Brennan KC, Loder E, Lipton R, Silbersweig D. A migraine management training program for primary care providers: An overview of a survey and pilot study findings, lessons learned, and considerations for further research. Headache. 2016 Apr; 56(4):725-40. PMID: 27037903; PMCID: PMC4890700 [Available on 04/01/17].
  23. Loder E, Groves T, Schroter S, Merino JG, Weber W, Godlee F. The BMJ editors respond. BMJ. 2016 Mar 15; 352:i1492. PMID: 26979466.
    View in: PubMed
  24. Loder E, Groves T, Schroter S, Merino JG, Weber W. Qualitative research and The BMJ. BMJ. 2016 Feb 10; 352:i641. PMID: 26865061.
    View in: PubMed
  25. Loder E, Chen V. Restructured abstracts for research in The BMJ. BMJ. 2015 Oct 22; 351:h5499. PMID: 26493220.
    View in: PubMed
  26. Rayhill ML, Sharon R, Burch R, Loder E. Registration status and outcome reporting of trials published in core headache medicine journals. Neurology. 2015 Nov 17; 85(20):1789-94. PMID: 26475691.
    View in: PubMed
  27. Sharon R, Rayhill ML, Kurth T, Loder E. Headache Rounds: Sudden, Transient Neurologic Symptoms in a Woman With Migraine. Headache. 2015 Oct; 55(9):1274-82. PMID: 26473747.
    View in: PubMed
  28. Minen MT, Lindberg K, Wells RE, Suzuki J, Grudzen C, Balcer L, Loder E. Survey of Opioid and Barbiturate Prescriptions in Patients Attending a Tertiary Care Headache Center. Headache. 2015 Oct; 55(9):1183-91. PMID: 26316376; PMCID: PMC4757493 [Available on 10/01/16].
  29. Weber WE, Merino JG, Loder E. Trial registration 10 years on. BMJ. 2015 Jul 06; 351:h3572. PMID: 26149708.
    View in: PubMed
  30. Minen MT, Loder E, Tishler L, Silbersweig D. Migraine diagnosis and treatment: A knowledge and needs assessment among primary care providers. Cephalalgia. 2016 Apr; 36(4):358-70. PMID: 26122646.
    View in: PubMed
  31. Loder E, Brizzell C, Godlee F. Revisiting the commercial-academic interface in medical journals. BMJ. 2015 Jun 02; 350:h2957. PMID: 26037508.
    View in: PubMed
  32. Loder E, Groves T. The BMJ requires data sharing on request for all trials. BMJ. 2015 May 07; 350:h2373. PMID: 25953153.
    View in: PubMed
  33. Macdonald H, Loder E. Too much medicine: the challenge of finding common ground. BMJ. 2015 Mar 04; 350:h1163. PMID: 25739770.
    View in: PubMed
  34. Loder S, Sheikh HU, Loder E. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache. 2015 Feb; 55(2):214-28. PMID: 25644596.
    View in: PubMed
  35. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015 Jan; 55(1):21-34. PMID: 25600719.
    View in: PubMed
  36. Rizzoli P, Weizenbaum E, Loder T, Friedman D, Loder E. The evolution and geographic distribution of headache medicine fellowship programs and graduates: an observational study. Headache. 2014 Nov-Dec; 54(10):1591-600. PMID: 25399855.
    View in: PubMed
  37. Minen MT, Loder E, Friedman B. Factors associated with emergency department visits for migraine: an observational study. Headache. 2014 Nov-Dec; 54(10):1611-8. PMID: 25339091.
    View in: PubMed
  38. Merino JG, Loder E. PCORI's ambitious efforts to promote transparency and dissemination of research findings. BMJ. 2014 Oct 20; 349:g6261. PMID: 25330779.
    View in: PubMed
  39. Groves T, Loder E. Prepublication histories and open peer review at the BMJ. BMJ. 2014 Sep 03; 349:g5394. PMID: 25186622.
    View in: PubMed
  40. Wells RE, Burch R, Paulsen RH, Wayne PM, Houle TT, Loder E. Meditation for migraines: a pilot randomized controlled trial. Headache. 2014 Oct; 54(9):1484-95. PMID: 25041058.
    View in: PubMed
  41. Strauss L, Loder E, Rizzoli P. Transient facial nerve palsy after occipital nerve block: a case report. Headache. 2014 Nov-Dec; 54(10):1651-5. PMID: 24913733.
    View in: PubMed
  42. Wells RE, Smitherman TA, Seng EK, Houle TT, Loder EW. Behavioral and mind/body interventions in headache: unanswered questions and future research directions. Headache. 2014 Jun; 54(6):1107-13. PMID: 24735261.
    View in: PubMed
  43. Loder E, Tovey D, Godlee F. The Tamiflu trials. BMJ. 2014 Apr 09; 348:g2630. PMID: 24811414.
    View in: PubMed
  44. Loder E, Weizenbaum E. Adding NSAIDs to triptans: could less be more? Cephalalgia. 2014 May; 34(6):407-8. PMID: 24335849.
    View in: PubMed
  45. Loder E, Weizenbaum E, Frishberg B, Silberstein S. Temporarily Withdrawn: Choosing Wisely in Headache Medicine: The American Headache Society's List of Five Things Physicians and Patients Should Question. Headache. 2013 Nov 08. PMID: 24205799.
    View in: PubMed
  46. Loder E, Weizenbaum E, Frishberg B, Silberstein S. Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question. Headache. 2013 Nov-Dec; 53(10):1651-9. PMID: 24266337.
    View in: PubMed
  47. Loder E, Burch R. What can data mining teach us about triptan safety that we don't already know? Cephalalgia. 2014 Jan; 34(1):3-4. PMID: 23918835.
    View in: PubMed
  48. Loder E. Sharing data from clinical trials: where we are and what lies ahead. BMJ. 2013 Jul 30; 347:f4794. PMID: 23900826.
    View in: PubMed
  49. Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013 Sep; 53(8):1278-99. PMID: 23808666.
    View in: PubMed
  50. Loder E, Godlee F, Barbour V, Winker M. Restoring the integrity of the clinical trial evidence base. BMJ. 2013 Jun 13; 346:f3601. PMID: 23766484; PMCID: PMC3685511.
  51. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ. 2013 Mar 25; 346:f1049. PMID: 23529982.
    View in: PubMed
  52. Loder E, Rizzoli P. Reply to: 'composite endpoints for detecting meaningful changes in trials of headache treatments'. Cephalalgia. 2013 May; 33(7):500. PMID: 23475295.
    View in: PubMed
  53. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013 Mar; 53(3):427-36. PMID: 23470015.
    View in: PubMed
  54. Loder EW, Rizzoli P. Detecting meaningful changes in trials of headache treatments: which outcome measure is best? Cephalalgia. 2012 Oct; 32(13):947-9. PMID: 23014636.
    View in: PubMed
  55. Wells RE, Loder E. Mind/Body and behavioral treatments: the evidence and approach. Headache. 2012 Oct; 52 Suppl 2:70-5. PMID: 23030535.
    View in: PubMed
  56. Loder E. Colonic explosions, chimpanzees' rear ends, and a source of green hair: this year's Ig Nobels. BMJ. 2012 Sep 21; 345:e6403. PMID: 23002152.
    View in: PubMed
  57. Burch RC, Rist PM, Winter AC, Buring JE, Pradhan AD, Loder EW, Kurth T. Migraine and risk of incident diabetes in women: a prospective study. Cephalalgia. 2012 Oct; 32(13):991-7. PMID: 22807568; PMCID: PMC3460043.
  58. Peters M, Perera S, Loder E, Jenkinson C, Gil Gouveia R, Jensen R, Katsarava Z, Steiner TJ. Quality in the provision of headache care. 1: systematic review of the literature and commentary. J Headache Pain. 2012 Aug; 13(6):437-47. PMID: 22736100.
    View in: PubMed
  59. Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012 Jun; 52(6):930-45. PMID: 22671714.
    View in: PubMed
  60. Loder E, Burch R. Measuring pain intensity in headache trials: which scale to use? Cephalalgia. 2012 Feb; 32(3):179-82. PMID: 22287565.
    View in: PubMed
  61. Lehman R, Loder E. Missing clinical trial data. BMJ. 2012 Jan 03; 344:d8158. PMID: 22214760.
    View in: PubMed
  62. Young WB, Kempner J, Loder EW, Roberts J, Segal JZ, Solomon M, Cady RK, Janoff L, Sheeler RD, Robert T, Yocum J, Sheftell FD. Naming migraine and those who have it. Headache. 2012 Feb; 52(2):283-91. PMID: 21929663.
    View in: PubMed
  63. Loder EW, Rizzoli P. Tolerance and loss of beneficial effect during migraine prophylaxis: clinical considerations. Headache. 2011 Sep; 51(8):1336-45. PMID: 21884088.
    View in: PubMed
  64. Rizzoli P, Loder EW. Tolerance to the beneficial effects of prophylactic migraine drugs: a systematic review of causes and mechanisms. Headache. 2011 Sep; 51(8):1323-35. PMID: 21884087.
    View in: PubMed
  65. Loder E. A theme issue in 2011 on unpublished evidence. BMJ. 2011 Apr 28; 342:d2627. PMID: 21527457.
    View in: PubMed
  66. Napchan U, Buse DC, Loder EW. The use of marijuana or synthetic cannabinoids for the treatment of headache. Headache. 2011 Mar; 51(3):502-5. PMID: 21462433.
    View in: PubMed
  67. Loder E, Cardona L. Evaluation for secondary causes of headache: the role of blood and urine testing. Headache. 2011 Feb; 51(2):338-45. PMID: 21284621.
    View in: PubMed
  68. Godlee F, Loder E. Missing clinical trial data: setting the record straight. BMJ. 2010 Oct 12; 341:c5641. PMID: 20940217.
    View in: PubMed
  69. Loder E. Manual therapy versus usual GP care for chronic tension-type headache: we now have better evidence, but important questions remain. Cephalalgia. 2011 Jan; 31(2):131-2. PMID: 20921025.
    View in: PubMed
  70. Klein AM, Loder E. Postpartum headache. Int J Obstet Anesth. 2010 Oct; 19(4):422-30. PMID: 20833030.
    View in: PubMed
  71. Loder E. Triptan therapy in migraine. N Engl J Med. 2010 Jul 01; 363(1):63-70. PMID: 20592298.
    View in: PubMed
  72. Loder E. Design considerations in migraine with aura trials: learning from experience. Cephalalgia. 2010 Sep; 30(9):1027-8. PMID: 20713552.
    View in: PubMed
  73. Loder E, Groves T, Macauley D. Registration of observational studies. BMJ. 2010 Feb 18; 340:c950. PMID: 20167643.
    View in: PubMed
  74. Loder E. The approach to the difficult patient. Handb Clin Neurol. 2010; 97:233-8. PMID: 20816424.
    View in: PubMed
  75. Loder E. Migraine with aura and increased risk of ischaemic stroke. BMJ. 2009 Oct 27; 339:b4380. PMID: 19861379.
    View in: PubMed
  76. Tfelt-Hansen P, Bjarnason NH, Dahlöf C, Derry S, Loder E, Massiou H. Evaluation and registration of adverse events in clinical drug trials in migraine. Cephalalgia. 2008 Jul; 28(7):683-8. PMID: 18498392.
    View in: PubMed
  77. Loder E. Prophylaxis: headaches that never happen. Headache. 2008 May; 48(5):694-6. PMID: 18471113.
    View in: PubMed
  78. Solomon S, Diamond S, Mathew N, Loder E. American headache through the decades: 1950 to 2008. Headache. 2008 May; 48(5):671-7. PMID: 18471107.
    View in: PubMed
  79. Evans RW, Rizzoli P, Loder E, Bana D. Beta-blockers for migraine. Headache. 2008 Mar; 48(3):455-60. PMID: 18302703.
    View in: PubMed
  80. Loder E, Rizzoli P. Tension-type headache. BMJ. 2008 Jan 12; 336(7635):88-92. PMID: 18187725; PMCID: PMC2190284.
  81. Loder E. Migraine in pregnancy. Semin Neurol. 2007 Nov; 27(5):425-33. PMID: 17940921.
    View in: PubMed
  82. Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB. Body mass index and episodic headaches: a population-based study. Arch Intern Med. 2007 Oct 08; 167(18):1964-70. PMID: 17923596.
    View in: PubMed
  83. Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes. 2007 Oct 04; 5:56. PMID: 17916258; PMCID: PMC2093930.
  84. Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine. Pain Med. 2007 Sep; 8(6):478-85. PMID: 17716321.
    View in: PubMed
  85. Mannix LK, Loder E, Nett R, Mueller L, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia. 2007 May; 27(5):414-21. PMID: 17448179.
    View in: PubMed
  86. Loder E, Rizzoli P, McGeeney B, Ward T, Levin M, Shapiro RE, Tepper S, Newman L, Sheftell F, Rapoport A, Markley H. Cluster headache treatment dilemmas: the experts respond. Curr Pain Headache Rep. 2007 Apr; 11(2):141-7. PMID: 17367594.
    View in: PubMed
  87. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache. 2007 Mar; 47(3):355-63. PMID: 17371352.
    View in: PubMed
  88. Silberstein S, Loder E, Diamond S, Reed ML, Bigal ME, Lipton RB. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007 Mar; 27(3):220-9. PMID: 17263769.
    View in: PubMed
  89. Loder E, Rizzoli P, Golub J. Hormonal management of migraine associated with menses and the menopause: a clinical review. Headache. 2007 Feb; 47(2):329-40. PMID: 17300386.
    View in: PubMed
  90. Loder EW. Menstrual migraine: pathophysiology, diagnosis, and impact. Headache. 2006 Oct; 46 Suppl 2:S55-60. PMID: 17044842.
    View in: PubMed
  91. Loder E, Rizzoli P. Biomarkers in migraine: their promise, problems, and practical applications. Headache. 2006 Jul-Aug; 46(7):1046-58. PMID: 16866709.
    View in: PubMed
  92. Loder E, Harrington MG, Cutrer M, Sandor P, De Vries B. Selected confirmed, probable, and exploratory migraine biomarkers. Headache. 2006 Jul-Aug; 46(7):1108-27. PMID: 16866715.
    View in: PubMed
  93. Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S. The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin. 2006 Jun; 22(6):1021-9. PMID: 16846536.
    View in: PubMed
  94. Loder E. Cluster headache and the heart. Curr Pain Headache Rep. 2006 Apr; 10(2):142-6. PMID: 16539868.
    View in: PubMed
  95. Loder E. Post-marketing experience with an opioid nasal spray for migraine: lessons for the future. Cephalalgia. 2006 Feb; 26(2):89-97. PMID: 16426261.
    View in: PubMed
  96. Loder EW, Buse DC, Golub JR. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol. 2005 Sep; 193(3 Pt 1):636-49. PMID: 16150254.
    View in: PubMed
  97. Martin VT, Loder E, Taylor K, Almas M, Hilliard B. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study. Cephalalgia. 2005 Sep; 25(9):726-34. PMID: 16109055.
    View in: PubMed
  98. Loder E, Biondi D. Headache attributed to psychiatric disorder: a case series. Psychosomatics. 2005 Jul-Aug; 46(4):326-33. PMID: 16000675.
    View in: PubMed
  99. Loder EW, Sheftell F. The quality of headache treatment in the United States: review and analysis of recent data. Headache. 2005 Jul-Aug; 45(7):939-46. PMID: 15985114.
    View in: PubMed
  100. Loder E. Menstrual migraine: clinical considerations in light of revised diagnostic criteria. Neurol Sci. 2005 May; 26 Suppl 2:s121-4. PMID: 15926008.
    View in: PubMed
  101. Loder EW. Review: intravenous metoclopramide is better than placebo for reducing pain in acute migraine in the emergency department. ACP J Club. 2005 May-Jun; 142(3):77. PMID: 15862076.
    View in: PubMed
  102. Loder E, Biondi D. General principles of migraine management: the changing role of prevention. Headache. 2005 Apr; 45 Suppl 1:S33-47. PMID: 15833089.
    View in: PubMed
  103. Loder E. Cluster headache from the patient's point of view. Curr Pain Headache Rep. 2005 Apr; 9(2):120-5. PMID: 15745622.
    View in: PubMed
  104. Loder EW, Buse DC, Golub JR. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache. 2005 Mar; 45(3):224-31. PMID: 15836597.
    View in: PubMed
  105. Mathew NT, Loder EW. Evaluating the triptans. Am J Med. 2005 Mar; 118 Suppl 1:28S-35S. PMID: 15841885.
    View in: PubMed
  106. Loder E, Stein J. Stiff-person syndrome presenting with headache. Cephalalgia. 2005 Mar; 25(3):237-9. PMID: 15689200.
    View in: PubMed
  107. Lipton RB, Loder EW. Migraine: primary care challenges in diagnosis and treatment. Introduction. Am J Med. 2005 Mar; 118 Suppl 1:1S-2S. PMID: 15841881.
    View in: PubMed
  108. Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial. Curr Med Res Opin. 2005 Mar; 21(3):381-9. PMID: 15811207.
    View in: PubMed
  109. Loder EW, Lipton RB. Conclusion: how primary care physicians can help their patients with migraine. Am J Med. 2005 Mar; 118 Suppl 1:45S-46S. PMID: 15841887.
    View in: PubMed
  110. Loder E, Goldstein R, Biondi D. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls. Cephalalgia. 2005 Feb; 25(2):124-31. PMID: 15658949.
    View in: PubMed
  111. Loder E. Fixed drug combinations for the acute treatment of migraine : place in therapy. CNS Drugs. 2005; 19(9):769-84. PMID: 16142992.
    View in: PubMed
  112. Loder EW, Dowson AJ, Spierings EL. Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine. Curr Med Res Opin. 2005; 21 Suppl 3:S8-12. PMID: 16083518.
    View in: PubMed
  113. Evans RW, Loder E, Biondi DM. When can successful migraine prophylaxis be discontinued? Headache. 2004 Nov-Dec; 44(10):1040-2. PMID: 15546270.
    View in: PubMed
  114. Loder E. Menstrual migraine: timing is everything. Neurology. 2004 Jul 27; 63(2):202-3. PMID: 15277607.
    View in: PubMed
  115. Loder EW, Biondi DM. Off-label prescribing of drugs in specialty headache practice. Headache. 2004 Jul-Aug; 44(7):636-41. PMID: 15209684.
    View in: PubMed
  116. Loder E. Migraine diagnosis and treatment. Prim Care. 2004 Jun; 31(2):277-92, vi. PMID: 15172507.
    View in: PubMed
  117. Loder E, Loder J. Medicolegal issues in cluster headache. Curr Pain Headache Rep. 2004 Apr; 8(2):147-56. PMID: 14980150.
    View in: PubMed
  118. Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study. Headache. 2004 Feb; 44(2):120-30. PMID: 14756849.
    View in: PubMed
  119. Loder E, Martin V, editors . Headache. 2004.
  120. Loder E, Marcus D, editors. . Migraine in Women. 2004.
  121. Loder E, Biondi D. Oral phenobarbital loading: a safe and effective method of withdrawing patients with headache from butalbital compounds. Headache. 2003 Sep; 43(8):904-9. PMID: 12940814.
    View in: PubMed
  122. Loder E. Who will prescribe? A proposal for specialized opioid management clinics. Pain Pract. 2003 Sep; 3(3):218-21. PMID: 17147670.
    View in: PubMed
  123. Loder E. More on migraine and coronary artery disease. Headache. 2003 Jun; 43(6):697; author reply 696-7. PMID: 12786936.
    View in: PubMed
  124. Loder E, Biondi D. Disease modification in migraine: a concept that has come of age? Headache. 2003 Feb; 43(2):135-43. PMID: 12558770.
    View in: PubMed
  125. Loder E. Safety of sumatriptan in pregnancy: a review of the data so far. CNS Drugs. 2003; 17(1):1-7. PMID: 12467489.
    View in: PubMed
  126. Evans RW, Loder EW. Migraine with aura during pregnancy. Headache. 2003 Jan; 43(1):80-4. PMID: 12864766.
    View in: PubMed
  127. Loder E, Witkower A, McAlary P, Huhta M, Matarrazzo J. Rehabilitation hospital staff knowledge and attitudes regarding pain. Am J Phys Med Rehabil. 2003 Jan; 82(1):65-8. PMID: 12510187.
    View in: PubMed
  128. Loder E. Prophylaxis of menstrual migraine with triptans: problems and possibilities. Neurology. 2002 Dec 10; 59(11):1677-81. PMID: 12481795.
    View in: PubMed
  129. Loder EW, Witkower AB. A pilot study of pain and attitudes toward pain in a rehabilitation population. Pain Med. 2002 Dec; 3(4):333-8. PMID: 15099238.
    View in: PubMed
  130. Loder E, Biondi D. Use of botulinum toxins for chronic headaches: a focused review. Clin J Pain. 2002 Nov-Dec; 18(6 Suppl):S169-76. PMID: 12569965.
    View in: PubMed
  131. Loder E. Review: several drugs, especially triptans, are effective for pain relief in acute migraine. ACP J Club. 2002 Nov-Dec; 137(3):103. PMID: 12418843.
    View in: PubMed
  132. Loder E. What is the evolutionary advantage of migraine? Cephalalgia. 2002 Oct; 22(8):624-32. PMID: 12383059.
    View in: PubMed
  133. Loder E, Geweke L. Volume and nature of telephone calls in a specialty headache practice. Headache. 2002 Oct; 42(9):883-7. PMID: 12390614.
    View in: PubMed
  134. Mannix LK, Diamond M, Loder E. Women and headache: a treatment approach based on life stages. Cleve Clin J Med. 2002 Jun; 69(6):488-500. PMID: 12061464.
    View in: PubMed
  135. Loder E. Sponsorship, authorship, and accountability. N Engl J Med. 2002 Jan 24; 346(4):290-2. PMID: 11808617.
    View in: PubMed
  136. Loder E. Naratriptan in the prophylaxis of cluster headache. Headache. 2002 Jan; 42(1):56-7. PMID: 12005276.
    View in: PubMed
  137. Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine. Headache. 2001 Sep; 41(8):745-53. PMID: 11576197.
    View in: PubMed
  138. Ferrari MD, Loder E, McCarroll KA, Lines CR. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia. 2001 Mar; 21(2):129-36. PMID: 11422095.
    View in: PubMed
  139. Loder E. Menstrual Migraine. Curr Treat Options Neurol. 2001 Mar; 3(2):189-200. PMID: 11180756.
    View in: PubMed
  140. Loder E, Geweke L. Toward optimal health: the experts respond to migraine. Interview by Jodi Godfrey Meisler. J Womens Health Gend Based Med. 1999 Jul-Aug; 8(6):739-44. PMID: 10495255.
    View in: PubMed
  141. Schachter SC, Richman K, Loder E, Beluk S. 1995;8(1):41-43. Self-reported characteristics of post-ictal headaches. J Epilepsy. 1995; 8(1):41-43.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Loder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (351)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.